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Abstract
A significant number of environmental microorganisms can cause serious, even fatal, acute and chronic infections in
humans. The severity and outcome of each type of infection depends on the expression of specific bacterial phenotypes
controlled by complex regulatory networks that sense and respond to the host environment. Although bacterial signals that
contribute to a successful acute infection have been identified in a number of pathogens, the signals that mediate the onset
and establishment of chronic infections have yet to be discovered. We identified a volatile, low molecular weight molecule,
2-amino acetophenone (2-AA), produced by the opportunistic human pathogen Pseudomonas aeruginosa that reduces
bacterial virulence in vivo in flies and in an acute mouse infection model. 2-AA modulates the activity of the virulence
regulator MvfR (multiple virulence factor regulator) via a negative feedback loop and it promotes the emergence of P.
aeruginosa phenotypes that likely promote chronic lung infections, including accumulation of lasR mutants, long-term
survival at stationary phase, and persistence in a Drosophila infection model. We report for the first time the existence of a
quorum sensing (QS) regulated volatile molecule that induces bistability phenotype by stochastically silencing acute
virulence functions in P. aeruginosa. We propose that 2-AA mediates changes in a subpopulation of cells that facilitate the
exploitation of dynamic host environments and promote gene expression changes that favor chronic infections.
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Introduction
Bacteria excrete small molecules that act as specific chemical
signals to positively regulate specialized processes [1], including
the production of virulence factors important for pathogenic
infection, host colonization, and interspecies microbial interactions
[2]. Using interconnected multi-layered regulatory networks, such
as quorum sensing (QS) networks, bacteria sense and respond to
external and internal bacterial cell signals as well as environmental
cues, thereby adapting to exploit target hosts. Adaptation and
coordination of gene expression is particularly important for
pathogenic microorganisms that need to colonize changing host
environments since their ability to sense and respond to host
environmental cues is crucial for their survival.
Pseudomonas aeruginosa is an opportunistic human pathogen that
causes chronic and acute infections, and is a major agent of
morbidity and mortality in cystic fibrosis (CF) patients. Establish-
ment of chronic P. aeruginosa respiratory or wound infections
requires a complex adaptive process that mediates essential
physiological changes allowing bacterial cells to survive and persist
in a dynamic host environment. Although insights into chronic
infection pathways have been reported [3–7], the specific bacterial
signals that may promote the transition and/or adaptation of known
pathogens from an acute to a chronic infection remain unknown.
Many P. aeruginosa virulence factors associated with acute
infections are controlled by QS [8]. This pathogen has an
extensively studied complex QS-communication network that
facilitates cross-talk between organisms and impacts many P.
aeruginosa group-related behaviors including virulence [8]. There are
at least three known QS systems in P. aeruginosa: two are dependent
on the acyl-homoserine-lactone (AHL) QS transcription factors
LasR and RhlR [9], and a third is dependent on the 4-hydroxy-2-
alkylquinolines (HAQs) LysR-type transcription factor MvfR
(multiple virulence factor regulator) [10]. MvfR is critical for P.
aeruginosa acute infection through its control of genes involved in the
production of secreted virulence factors and in iron assimilation
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[10–13]. This regulator controls HAQ signaling and its own activity
by positively regulating the expression of genes in the pqsABCDE
[14] and phnAB [10] operons. These operons encode enzymes that
catalyze the biosynthesis of at least 59 distinct low molecular weight
compounds, most of which are structurally related to HAQs. While
two of the most abundant HAQs, [4-hydroxy-2-heptylquinoline
(HHQ) and 3,4-dihydroxy-2-heptylquinoline (Pseudomonas Qui-
nolone Signal-PQS)] [14–16], function in vivo as ligands that bind
and activate MvfR [14,17], the biological functions of other
PqsABCD/PhnAB biosynthetic products remain elusive.
In this study, we show that one of these abundant MvfR-
regulated non-HAQ low molecular weight molecules, 2-aminoa-
cetophenone (2-AA), that is used to diagnose P. aeruginosa infections
in humans [18], reduces acute virulence by negatively fine-tuning
the transcription and synthesis of the MvfR ligand HHQ, and
promotes changes that are critical for pathogen adaptation and
important for chronic infection.
Results/Discussion
2-AA Synthesis Is Controlled by MvfR but Is Not Required
for the Activation of Its Regulon
To determine the functions of the abundant MvfR-regulated
small molecules, we first compared the liquid chromatography/
mass spectrometry (LC/MS) total ion chromatograms of culture-
free supernatants from highly pathogenic wild-type P. aeruginosa
(PA14) cells versus those of isogenic mvfR mutant cells. As shown in
Figure 1A, the mvfR versus PA14 supernatant lacked HHQ and
PQS, as well as three other abundant low molecular weight
compounds: the HAQ molecule 4-hydroxy-2 heptylquinoline N-
oxide (HQNO) [19], 2,4-dihydroxyquinoline (DHQ) [20], and the
non-HAQ molecule 2-AA. 2-AA is a relatively simple, non-HAQ
volatile molecule responsible for the grape-like odor of P. aeruginosa
cultures as well as burn wounds infected with P. aeruginosa [18,21].
Along with DHQ and HQNO, 2-AA is also produced and
excreted by the HAQs-producing bacterium Burkholderia thailan-
densis [23] (Figure S1). Because HHQ and PQS both induce
pqsABCDE expression [14], we investigated whether these three
additional abundant molecules also induce expression of these
genes. Maximum levels of 2-AA in the cell supernatant vary from
micromolar to millimolar range depending on the growth medium
used [18,22]. We used Luria-Bertani (LB) broth media in
experiments examining the effects of exogenous 2-AA supplemen-
tation on pqs operon gene transcription. We chose to use LB broth
because it supports lower levels of 2-AA production
(37.5 mM=5 mg/ml Figure 1B) than other media [18]. Using a
pqsA-green fluorescence protein (GFP)(ASV)-transcriptional re-
porter fusion in a pqsA::H double mutant background that does not
produce any of these molecules (Figure S2), we exogenously added
to LB media the above molecules. HQNO only modestly induced
pqsABCDE expression, while DHQ and 2-AA did not induce
pqsABCDE expression (Figure 1C). This finding indicates that
unlike HHQ and PQS, 2-AA and DHQ molecules may have
biological roles other than activating pqs operon transcription.
2-AA Down-regulates the Expression of MvfR-regulated
Loci
The kinetics and dose-dependency effects of exogenously added
2-AA and DHQ on pqsA regulation were examined in greater
detail using WT cells carrying the pqsA-GFP(ASV) transcriptional
reporter fusion. Figure 2A shows that 2-AA, but not DHQ (Figure
S3A), greatly reduced pqsA expression, in a dose-dependent
manner, with 2-AA achieving the strongest inhibition at 200 mg/
ml (1.5 mM). Bacterial growth was unaffected by either 2-AA or
DHQ (Figure S3B and C). In light of these results, we focused our
subsequent experimental efforts on 2-AA.
We visualized pqsA-GFP expression under a fluorescent micro-
scope in the presence of a range of 2-AA concentrations. Surprisingly,
but in accordance with the established dose-dependent effects of 2-
AA, only a subpopulation of the cells showed a shut-down of pqsA-
GFP activity in the presence of 50 mg/ml (0.375 mM) 2-AA
(Figure 2B and C); a statistically significant number of cells had
turned off the pqsA expression though some still fluoresced strongly.
No fluorescing cells were seen at 200 mg/ml 2-AA (Figure 2B and C).
Thus 2-AA appears to promote phenotypic heterogeneity in a
genetically ‘‘homogenous’’ population and silence pqs operon
expression in a fraction of the cells, suggesting that MvfR active
and inactive cells co-exist to achieve a bistable phenotype [24]. The
size of the 2-AA responsive population increased with higher 2-AA
concentrations. The need for higher concentrations of 2-AA to
produce significant detectable transcriptional changes may be due to
the compound affecting only a subpopulation of cells.
2-AA inhibition of MvfR is likely mediated via negative
feedback regulation given that MvfR controls 2-AA synthesis
(Figure 1A). To corroborate our pqsA expression data, we
measured levels of HHQ in 2-AA treated cells and found that
HHQ production was also inhibited by 2-AA in a dose-dependent
manner (Figure 2D). Consistent with the view that 2-AA down-
regulates the MvfR regulon, we observed that 2-AA decreased
production of pyocyanin (Figure 2E) and pyoverdine (Figure 2F),
virulence factors whose synthesis depends on MvfR. A time course
study of 2-AA production (Figure 1B) showed that 2-AA levels did
not significantly decrease as occurs for the MvfR activators HHQ
and PQS (Figure 1B), indicating that the production kinetics and
stability of 2-AA are distinct from those of the MvfR activators.
Together, this convergence of data strongly suggests that 2-AA has
the novel biological activity of silencing the MvfR regulon.
2-AA Down-regulates pqsABCDE Operon Expression via
MvfR, and by Targeting HAQ Biosynthesis Enzymes
To elucidate the mechanism by which 2-AA inhibits the MvfR
regulon, we administered 2-AA together with HHQ to PA14
Author Summary
P. aeruginosa causes acute as well as chronic infections in
humans. In this paper we report the identification of a P.
aeruginosa small molecule, 2-AA, that modulates this
pathogen’s virulence to promote chronic infections. We
show that the synthesis of 2-AA, responsible for the grape-
like odor of P. aeruginosa cultures and of wound infections,
is controlled by the multiple virulence factor regulator
(MvfR) important for virulence in acute infections. 2-AA
reduces the production of MvfR-regulated acute virulence
factors, and attenuates acute virulence by negatively fine-
tuning the MvfR regulon activity. Moreover, we show that
2-AA adapts P. aeruginosa for chronic infections by
promoting mutations in a key acute virulence gene (lasR)
and by prolonging bacterial survival. The findings present-
ed here reveal the function of a new MvfR-regulated
molecule, and highlight MvfR’s importance as a highly
promising target for the development of inhibitors that
can simultaneously halt acute and chronic infections
caused by P. aeruginosa, and possibly by other pathogenic
bacteria. This study uncovers insights that paradigmatically
pave the way for the search of 2-AA-like small volatile
molecules that promote pathogen adaptation and estab-
lishment of chronic infections caused by foreboding
human pathogens.
Adaptation to Chronic Infection by 2-AA
PLoS Pathogens | www.plospathogens.org 2 August 2011 | Volume 7 | Issue 8 | e1002192
Figure 1. 2-AA synthesis is controlled by MvfR. (A) LC/MS total ion chromatograms show the relative percentage of the most abundant small
molecules in P. aeruginosa (PA14) (upper panel) and isogenic mvfR mutant (lower panel) supernatants after 9 h of growth. The most abundant
molecules in PA14 cultures that were absent in mvfR mutant cultures were: DHQ (1); 2-AA (2); HQNO (3); and HHQ+PQS (4+5). The abundant peaks
shown in mvfR are negligible compared to the amount of HHQ or PQS produced by PA14 since the percentage value on the Y axis is drawn with
respect to the most abundant molecule detected. (B) Production kinetics of 2-AA in PA14 supernatants in LB. PA14 growth is shown as OD600 nm on
the secondary Y axis versus time. The chemical structure of 2-AA is shown in the inset. (C) 2-AA is not a MvfR co-inducer. MvfR-dependent pqsA-
GFP(ASV) expression in the pqsA::pqsH mutant with or without exogenous molecules (10 mg/ml), reported as relative fluorescence versus time,
averaged for six replicates.
doi:10.1371/journal.ppat.1002192.g001
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isogenic pqsA::pqsH double mutant cells, which do not produce any
HAQs [14] or 2-AA (Figure S2) but have functional MvfR. The
expression of the pqsA reporter in pqsA::pqsH cells requires activation
of MvfR. While exogenous addition of HHQ to these cells induced
pqsA reporter expression via activation of MvfR, co-addition of 2-
AA, at 100 mg/ml (0.75 mM) and above, attenuated this expression
in a dose-dependent manner, suggesting that 2-AA may negatively
impact the MvfR-regulated operon pqsABCDE at the transcriptional
level (Figure 3A) via MvfR. Unlike other anthranilic acid analogs,
which act on PqsA activity and inhibit the synthesis of MvfR ligands
[25], the apparent 2-AA inhibition described here can be regarded
as independent of PqsA since the pqsA::pqsH mutant was used in
these experiments. Moreover, 2-AA did not perturb MvfR protein
levels or MvfR ligand stability (data not shown).
To assess whether down-regulation of MvfR activity by 2-AA is
due to reduced ligand levels, we engineered mvfR mutant cells to
Figure 2. 2-AA silences MvfR regulon in a subpopulation of cells and restricts HAQ mediated QS signaling relevant in acute
infection. (A) Quantification of pqsA-GFP(ASV) expression in PA14 cells in response to increasing 2-AA concentration (mg/ml); the error bar
represents the standard deviation of the 6 replicates. The difference in fluorescence intensity at the peak was statistically significant at all
concentrations with p values,0.005. (B) Expression of pqsA-GFP(ASV) in response to 2-AA (mg/ml). Images of total number of cells in the optical field
as assessed by membrane staining (red) and bacterial cells expressing pqsA-GFP(ASV)(green). (C) Quantification of pqsA expressing cells (percentage
of green/red) in response to each 2-AA concentration. (D) Production of HHQ in supernatants collected from PA14 cells (OD 2.0) with exogenously
added 2-AA at 0–200 mg/ml HHQ levels were quantified in triplicate by LC/MS. The error bars represent the standard deviation from triplicate
samples. (E) Levels of pyocyanin in PA14 cultures grown (to OD 3.0) in LB and LB supplemented with varying (0–200 mg/ml) concentrations of 2-AA.
Error bars represent standard deviation of the triplicate samples. These experiments were repeated at least three times with similar results. (F) Kinetics
of pyoverdine production in the presence of 100 and 200 mg/ml of 2-AA. (-) indicates no exogenously added 2-AA.
doi:10.1371/journal.ppat.1002192.g002
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synthesize HHQ independently of MvfR by constitutively
expressing pqsABCD. These cells produced HHQ in the absence
of 2-AA whereas HHQ production decreased in the presence of 2-
AA in a dose-dependent manner (Figure 3B), indicating that
inhibition of the MvfR regulon can also occur independently of
MvfR. This post-transcriptional inhibition could be mediated
through interference with ligand biosynthesis.
The pqsABBCDE operon gene pqsA is required for the synthesis
of 2-AA and HHQ (Figure S2). In our effort to understand 2-AA
biosynthesis, we created various mutants in the PQS operon.
Surprisingly, the pqsB::C mutant produced 2-AA in the absence of
HHQ (Figure S2), demonstrating that neither pqsB and pqsC is
required for 2-AA synthesis. Addition of PQS to pqsB::C mutant
cultures induced pqs operon transcription, resulting in WT levels of
2-AA (Figure S2). However, as expected the addition of PQS did
not result in production of HHQ (data not shown).
We used pqsB::C mutant cells with an additional, more sensitive
reporter system to further assess the effects of endogenous 2-AA
produced by the pqsB::C mutant on transcription of the mvfR
regulon and its biological relevance in the absence of HHQ, as
well as to quantify 2-AA effects on the pqs operon. We fused the
pqsA promoter to the Bacillus subtilis sacB gene that codes for the
levansucrase product, which is toxic when cells are grown in the
presence of sucrose. The sacB gene has previously been
incorporated into allelic exchange vectors as a means of counter-
selection [23]. As shown in Figures 3C and S4, PA14 cells with the
pqsA-sacB fusion gene incorporated stably into their chromosome
did not grow in the presence of sucrose, while the corresponding
isogenic pqsB::C mutant cells did grow significantly, corroborating
the findings that 2-AA suppresses pqsA promoter activation and
indicating that this effect is stronger in the absence of HHQ.
Bacterial cell proliferation occurred even following exogenous
Figure 3. Negative regulation of the MvfR regulon by 2-AA is a result of down-regulation of pqsABCDE expression and interference
with MvfR activity via inhibition of HHQ biosynthesis. (A) pqsA promoter response was assessed by measuring pqsA-LacZ expression in the
PA14 isogenic pqsA::pqsH double mutant in the presence of HHQ (10 mg/ml) or HHQ together with 2-AA at the indicated concentrations. b-
galactosidase activity is given in Miller Units, and plotted against growth assessed at OD600 nm. The experiment was repeated three times with similar
results. (B) Levels of HHQ in the supernatant (OD 2.0) of PA14 andmvfRmutant cells constitutively expressing pqsABCD on a plasmid. HHQ levels were
quantified in triplicate by LC/MS. The error bars represent the standard deviation of triplicate samples. (C) Growth of PA14 and pqsB::C mutant cells
carrying pqsA-SacB after 20 h of inoculation in the presence or absence of sucrose (10%), and/or with exogenously added various concentrations of 2-
AA. The pqsA promoter of pqsA-SacB in the pqsB::C mutant was induced by exogenous addition of 10 mg/ml HHQ where indicated. (D) Concentration
of pyocyanin in mvfR mutant cells (OD 3.0) over-expressing MvfR or PqsE under a constitutive promoter in the presence or absence of 2-AA (200 mg/
ml). Error bars represent standard deviations of triplicate samples. These experiments were repeated at least three times with similar results.
doi:10.1371/journal.ppat.1002192.g003
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addition of HHQ, which promotes further induction of the pqs
operon (Figure 3C and S4). Importantly, the endogenous level of
2-AA in the pqsB::C mutant cells in presence of the inducer, had a
suppression efficacy comparable to 100 mg/ml of exogenously
added 2-AA Figure 3C. These results are physiologically
important and consistent with the putative role of 2-AA in
down-regulation of MvfR regulon. These results also suggest there
may be limited uptake of exogenously added 2-AA thereby
requiring addition of higher concentrations of 2-AA to generate a
physiological response by exogenously added 2-AA.
The last gene in the pqs operon, pqsE, is essential for pyocyanin
production [16,26–27], but dispensable for HAQ synthesis
[12,15]. Importantly, 2-AA did not reduce pyocyanin in an mvfR
mutant that constitutively expressed pqsE, even though it efficiently
inhibited pyocyanin production when MvfR was constitutively
expressed (Figure 3D). Hence we can deduce that 2-AA negative
regulation of the MvfR regulon is a result of the down-regulation
of pqsABCDE operon expression and interference with MvfR
activity upstream of PqsE, via inhibition of HHQ biosynthesis.
2-AA Treatment Reduces the Mortality of PA14-infected
Flies and Mice
We have shown previously that P. aeruginosa pathogenesis can be
studied in Drosophila melanogaster [28–30]. Drosophila shares striking
similarities with mammals in terms of its overall physiology and
innate immunity signal transduction pathway components [28,31].
P. aeruginosa strain PA14 is highly virulent in flies, causing high
mortality; meanwhile, mvfR mutants exhibit reduced virulence,
causing reduced mortality [30]. Therefore, since 2-AA negatively
regulates MvfR, we first tested whether it reduces P. aeruginosa
virulence in Drosophila. As shown in the Figure 4A, flies co-injected
with P. aeruginosa and 2-AA succumb to infection significantly later
than flies injected with only P. aeruginosa.
To confirm the in vivo efficacy of 2-AA in attenuating the
virulence of PA14 cells and validate the above findings in a
mammalian model of infection, we used the well-studied acute
mouse burn and infection model [32], in which we have shown
previously that mvfR mutant cells cause attenuated virulence
[10,25]. Indeed, as shown in Figure 4B, 2-AA also attenuated the
virulence of PA14 cells in mice. Mice inoculated with PA14 and
injected once with 2-AA survived significantly longer than control
mice inoculated with PA14 alone. Importantly, this effect could
not have been due to reduced PA14 proliferation since 2-AA did
not affect the bacterial colony forming units (CFUs) in the muscle
tissue underlying the burn injury and infection site (Figure 4C).
Importantly, 2-AA greatly hampered the systemic spread of
bacteria in the blood of the infected mice (Figure 4D), which is a
significant problem in humans with P. aeruginosa infections.
Silencing of MvfR regulon activity, and thus of acute virulence
factor gene expression, is likely responsible in large part for the
reduced systemic dissemination of PA14 cells and attenuated PA14
virulence observed.
2-AA Promotes the Emergence of P. aeruginosa
Phenotypes that likely Promote Chronic Lung Infections
One may wonder why a pathogen such as P. aeruginosa would
produce a molecule that decreases its own virulence. However,
given that successful adaptation of an organism depends on its
ability to regulate gene expression in response to its changing
environment and thereby maximize its long-term survival, the
existence of such a mechanism should not be surprising. There is
ongoing debate regarding the role of QS in chronic infection due
to inactivation of LasR in P. aeruginosa isolates from CF sputum,
while a lack of QS has been proposed to facilitate adaptation
during a chronic infection [33]. Since 2-AA down-regulates the
expression of QS-related acute virulence functions, we questioned
if the same molecule could promote other functions that support
adaptation during chronic infections. We therefore examined a
variety of phenotypes associated with chronic infection by P.
aeruginosa.
A significant fraction of P. aeruginosa cells isolated from
chronically infected CF patients accumulate multiple mutations
in genes affecting acute virulence functions, including mucA, the
regulator of alginate production, the QS regulator LasR, type III
secretion system, multidrug efflux pumps, genes involved in
motility, and DNA repair genes such as mutS [2,34–38]. Mutations
in the lasR gene are particularly notable, not only because they
accumulate in bacteria colonizing the lungs of chronically infected
CF patients, but also because they have been shown to promote
long-term growth and survival of CF isolates in vitro [33].
Therefore, we first examined the frequency of occurrence of lasR
mutations in populations of P. aeruginosa grown in the presence of
increasing concentrations of 2-AA. We found that PA14 cells
exposed to increasing 2-AA concentrations for 10 d accumulated
significantly more lasR mutations than untreated cells (Figure 5A).
Sequence analysis showed that these lasR mutant lines harbor
simple deletions or single nucleotide non-synonymous mutations in
the lasR gene that produce inactive LasR protein (Table 1). One of
the lasR mutant lines also carried mutations in the intergenic
region of the fleQ flagellar gene regulator, which is important for
motility, and five clones carried mutations in the intergenic region
of mexT, a regulator of multidrug efflux. Mutations in these genes
lead to loss of flagellar motility and antibiotic resistance,
respectively [39–40]. However, no mutations in the DNA repair
gene mutS, in type III secretion system genes (exsA, pscQ and popD),
or in the virulence factor vfR or rpoN, which are also associated
with chronic infections [2], were identified in any of the lasR
mutant lines sequenced. Additionally, 2-AA does not appear to be
mutagenic, as it did not stimulate mutagenesis in a standard Ames
test (data not shown). We did not identify any mutation in lasR
within a day of incubation when silencing of mvfR was observed,
suggesting that it’s silencing is not due to the loss of lasR.
Nevertheless, the ability of 2-AA to promote lasR mutations was
particularly pronounced after 10 d of incubation in isogenic mutS
cells (Figure 5A), which are defective in DNA repair function. In
contrast to the 2-AA dependent non-linear accumulation of lasR
mutants observed in the WT background, a more linear
accumulation of lasR mutants in the mutS mutant background is
observed (Figure 5A). These data suggest that once a DNA repair
mechanism is compromised, as in mutS mutants commonly found
in P. aeruginosa cultures from CF sputum [37–38], 2-AA effect is
more prominent.
Although the mechanisms and advantages of lasR mutations are
not clearly understood, it has been proposed that lasR mutation
may provide a growth advantage [33]. We further tested the
effects of 2-AA on long-term survival of P. aeruginosa. When grown
under the condition of limited iron and aeration, PA14 cells reach
stationary phase within 10–12 h and undergo significant lysis after
40 h (Figure 5B). However, addition of 2-AA inhibited entry into
the lytic phase and the treated cells remained in stationary phase,
promoting bacterial cell long-term survival (Figure 5B). To
investigate whether 2-AA can also promote long-term survival in
vivo, we developed a non-vertebrate, whole animal persistence
infection assay in Drosophila melanogaster. Using the fly-P. aeruginosa
feeding assay [28], flies were fed for 2 d with P. aeruginosa WT
(PA14), 2-AA non-producer PA14 isogenic mutant strain pqsA, and
the 2-AA producer strain pqsB::C. Flies were then transferred onto
Adaptation to Chronic Infection by 2-AA
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bacteria-free food, and the CFUs were quantified at 7 d post-
feeding. Bacterial load decreased over time in the pqsA-infected
flies, while flies infected with the 2-AA producing strains PA14 and
pqsB::C sustained ,3 log greater CFUs (Figure 5C), indicating that
2-AA helps bacteria to survive and persist, and thus promotes
better fitness in a dynamic host environment. Due to the longer
incubation duration, we cannot rule out the possibility that the
persistence seen here may be due to lasR mutation induced by 2-
AA. Together with the above in vitro studies, these in vivo results
corroborate the view that 2-AA plays a key role in switching cells
to a phase that promotes concomitant adaptations that enable P.
aeruginosa to persist in a chronic infection.
Synthesis of HAQs Analogs of Burkholderia are also
Inhibited by 2-AA
Production of the 2-AA has been reported in plants,
invertebrate animals, and vertebrate animals, including humans
[41]. Moreover, several plant and human eubacterial pathogens,
including Pseudomonas, Bordetella, Burkholderia, Ralstonia, Streptomyces,
and Mycobacteria, as well as the Archeae Sulfolobus, encode putative
PqsA and MvfR homologues, and in some cases, pqsBCD-related
loci [42]. As such, these species might also produce 2-AA and use
this molecule to down-regulate their respective virulence functions.
Indeed, Burkholderia thailandensis, highly related and often used as a
non-pathogenic surrogate for the level 3 pathogen B. pseudomallei,
was confirmed to produce 2-AA (Figure S1). We assessed whether
this 2-AA could inhibit HAQ biosynthesis in B. thailandensis, and
found that exogenous 2-AA inhibited production of the HHQ and
HNQ methylated analogs HMHQ and HMNQ (Figure S5A and
B) [23], suggesting that 2-AA may perform analogous functions in
B. thailandensis as observed in P. aeruginosa. 2-AA producing species
may have a selective advantage in mixed microbial communities
by adversely influencing the expression or activities of fitness traits
of their neighbors.
Here we provide evidence that 2-AA, a small volatile molecule
produced by P. aeruginosa (and B. thailandensis), is a QS regulated
molecule and an important modulator of acute and chronic
virulence functions. Although much work has focused on how QS
cell-cell signaling leads to the activation of a plethora of virulence
factors, little is known about the silencing of these factors.
Degradation of AHL by an AHL acylase [43] and interference of
LasR and RhlR binding to their promoter by the transcription
factors QscR [44] and RsaL [45] have been shown to down-
regulate AHL mediated QS. We recently demonstrated the
existence of an interplay between QS systems, their components,
and environmental factors that negatively impact HAQs [27].
However, no signaling molecule has been identified to date that
negatively regulates acute virulence QS related functions or
promotes bacterial adaptation and long-term persistence. Further-
more, no volatile compounds have been reported to be involved in
Figure 4. 2-AA reduces P. aeruginosa virulence. (A) Survival kinetics of flies injected with a PA14 bacterial suspension with (,1.6 ng/fly) and
without 2-AA. Data were averaged from two experiments with n(PA14) = 55 and n(PA14+2-AA) = 56. Significance of difference of survival rate was
calculated using the log-rank test of the Kaplan Meier survival estimate (p= 0.0056). (B) Survival rates of mice infected with PA14 versus PA14 + 67 mg
of 2-AA/mouse. The data correspond to the averages of two independent experiments, with n(PA14) = 20 and n(PA14+2-AA) = 20. Significance of
difference of survival rates was calculated using the Kaplan-Meier method (p= 0.03), with a hazard ratio of 1.8932 (95% CI, 1.0664 to 6.0718). (C and D)
Bacterial loads in the local and adjacent muscle and in blood were determined for control and 2-AA treated mice, at 20 h post-burn and infection. The
statistical significance of the CFU/mg muscle tissue differences between the control and experimental mice were determined using the Mann-
Whitney test for independent samples, with p= 0.43 for the difference in the underlying and adjacent muscle in response to 2-AA, and p=0.045 for
the difference in the blood in response to 2-AA. CFU data are presented as log 10. Black PA14, red PA14+2-AA, green 2-AA only.
doi:10.1371/journal.ppat.1002192.g004
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QS regulation and virulence. Our results demonstrate that the low
molecular weight molecule 2-AA silences the MvfR regulon via a
negative feedback mechanism, most likely via repressed synthesis
of MvfR ligands transcriptionally and post-transcriptionally, which
restricts HAQ-mediated QS signaling and thus acute virulence
functions, thereby enabling chronic infection. We propose the idea
that there may be QS regulated aerial communication among
bacteria, as 2-AA is a QS-regulated molecule and a volatile signal
[46]. Such aerial communication may occur and be critical in a
microenvironment such as the one found in biofilms and in
infected wounds or CF lungs. It is important to note that
suboptimal inhibitory concentration of 2-AA affects only a
subpopulation of cells, suggesting that MvfR active and inactive
cells co-exist causing a bistable phenotype. Similar bi/multi-
stability phenotypes have been described as naturally occurring for
several well known systems regulated by feedback mechanism,
such as regulation of the Lac operon in E. coli, mucoidy in P.
aeruginosa, lysogeny of the lambda phage, and transformation
competency and sporulation in B. subtilis [24,47]. In our model
(Figure 5D), we propose that 2-AA inhibits MvfR via feedback
regulation and promotes longer cell survival in vitro and in vivo in
flies, presumably by interfering with cell lysis and inducing
mutations in lasR. Additionally, the accumulation of lasR
mutations that allow adaptation to low oxygen conditions [48]
suggest that this mechanism contributes to overall pathogen fitness
in chronic infections. Whether, lasR mutations arise in WT cells,
MvfR silenced cells, and/or metabolically altered cells, remains to
be determined. In corroboration, the Drosophila persistence assay
showed that 2-AA promotes bacterial long-term survival and as
such fitness.
Assessment of the potential role of 2-AA in the establishment
and persistence of chronic infections has been hindered by a lack
of clinically relevant chronic infection models. Nevertheless, the
Drosophila persistence assay, using 2-AA producing and non-
producing isogenic strains, permits us to at least determine the
impact of this small molecule in a dynamic host environment that
shares many immune functions with the human. Our identifica-
tion of a P. aeruginosa QS regulated volatile molecule that limits
Figure 5. 2-AA promotes phenotypes associated with pathogenic bacteria at chronic infection sites. (A) 2-AA promotes increased
accumulation of lasR mutations in PA14 and mutS cells in a concentration-dependent manner. Data are averages of two independent experiments,
performed in triplicate. Significance of difference in number of lasR mutants was calculated using Student’s t-test, assuming equal variance. Asterisks
represent significant differences relative to the untreated control group. For both PA14 and mutS mutant cells, lasR mutant accumulation was
significantly increased with 100 mg/ml and 200 mg/ml 2-AA (p’s= 0.02 and 0.0001 for PA14, and p’s = 0.05 and 0.01 for mutS, respectively). (B) 2-AA
promotes prolonged stationary phase growth. Untreated PA14 cells began to lyse by 40 h, whereas PA14 cells treated with 2-AA at all tested
concentrations did not. (C) 2-AA promotes persistent infection in flies. Bacterial CFUs per fly were assessed at 7 d post-P. aeruginosa feeding (6–9 flies
per time point). Significant differences in CFUs after 7 d were seen for pqsA (pink) versus PA14 (black) or pqsB::C (green); Student’s t-test p values are
indicated in the figure. The data presented were combined from two independent experiments. (D) A model for 2-AA function. As the volatile
(squiggly grey lines) 2-AA accumulates overtime in a microenvironment (i.e. biofilms, wounds or CF lungs) it creates a heterogeneous population of
cells that consists of WT and physiologically and genetically different cells. The unaltered WT cells undergo lysis. On the other hand, the
subpopulation of cells with silenced MvfR can continue to accumulate mutations that are beneficial for adaption to chronic infection.
doi:10.1371/journal.ppat.1002192.g005
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virulence and invasive functions associated with acute infections
while promoting phenotypic and genetic changes associated with
chronic infection elucidates novel avenues for combating bacterial
adaptation and survival in the chronic infection environment.
These results also suggest that interfering with the MvfR pathway
could prevent both acute and chronic infections and that 2-AA
synthesis provides a potential target for the development of new
anti-virulence drugs in the combatance of P. aeruginosa, and
possibly of other pathogenic bacteria such as Burkholderia. This
study uncovers insights that paradigmatically pave the way for the
search for 2-AA-like volatile small molecules that promote
pathogen adaptation and establishment of chronic infections
caused by foreboding human pathogens.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. The protocol was
approved by the Committee on the Ethics of Animal Experiments of
the Massachusetts General Hospital (Permit Number: 2006N00
0093/2). All Procedures were performed under sodium pentobarbital
anesthesia, and all efforts were made to minimize suffering.
Bacterial Strains and Growth Conditions
A P. aeruginosa strain known as RifR human clinical isolate UCBPP-
PA14 (PA14) was used in the present experiments [11]. All of the
PA14 mutants described in this paper are isogenic to UCBPP-PA14.
The bacteria were grown at 37uC on LB broth or on plates of LB agar
containing appropriate antibiotics unless otherwise indicated. The
overnight PA14 cultures were grown in LB and diluted the following
day in fresh media with or without 2-AA. Bacterial growth kinetics
was determined by taking OD600 nm measurements.
LC/MS
Quantification of 2-AA and HAQs in bacterial culture
supernatants was performed as described previously [14,49].
The HAQs were separated on a C18 reverse-phase column
connected to a triple quadrupole mass spectrometer, using a
water/acetonitrile gradient [49]. Positive electrospray in MRM
mode with 261023 mTorr argon and 30 V as the collision gas
and energy was employed to quantify 2-AA and HAQs, using the
following ion transitions: 2-AA 136.91, HHQ 244.159, HHQ-
D4 248.163, PQS 260.175, and PQS-D4 264.179. To
quantify HAQs, Pseudomonas PA14 cells were grown in LB
supplemented with different concentrations of 2-AA (Sigma,
USA), with untreated LB being used as a negative control. The
culture supernatant was collected at different stages of growth
mixed with an equal volume of methanol, and the compounds
were analyzed by LC/MS. All samples were analyzed in
triplicate.
Bacterial Growth Curves
Bacterial cells were diluted 1/100 from overnight cultures and
grown in six replicates in 20 ml in a 96-well plate (Corning, Inc.,
Corning, NY). Bacterial growth was measured as a function of
optical density at OD600 nm using Tecan F200 automated plate
reader (Infinite F200, Tecan Group Ltd, Ma¨nnedorf, Switzerland).
For the pqsA-sucB assay, the bacteria were diluted from
overnight cultures to OD600 nm 0.1 in NaCl-free LB with
tetracycline (50 mg/ml) and grown (Sigma, USA), with or without
10% sucrose (200 ml). Growth was measured in triplicate every
30 min for up to 25 h, using a Sunrise plate reader (Tecan Group
Ltd, Ma¨nnedorf, Switzerland).
For lysis experiments, the LB medium was treated with Chelex
100 resin 100–200 mesh, sodium glutamate (50 g/l)(BioRad,
Hercules, CA) for 1 h followed by filtration with 0.2 mm filters
(Corning, NY). Bacterial cells were diluted 1/100 in presence of
various concentrations of 2AA. Triplicates (200 ml volumes) were
inoculated in 96 wells plates. The plates were incubated and
growth was recorded every 30 min for 3 d using a Sunrise plate
reader (Tecan Group Ltd, Ma¨nnedorf, Switzerland).
pqsA-GFP(ASV) Fluorescence Measurement and pqsA-
LacZ, ß-galactosidase Assay
PA14 or pqsA::pqsH cells carrying pAC37 plasmids with pqsA
promoter fused to short-lived GFP {pqsA-GFP(ASV)} [50] were
grown overnight in LB supplemented with gentamycin (50 mg/ml).
The cultures were diluted in the morning with the test compound at
desired concentrations and aliquoted (200 ml) into 6 replicates in a
96-well assay plate (Corning, Inc. Corning, NY). Green fluorescent
protein (GFP) fluorescence (excitation at 485 nm, emission at
535 nm) and OD600 nm for growth was measured every 30 min
using a Tecan F200 automated plate reader (Infinite F200, Tecan
Group Ltd, Ma¨nnedorf, Switzerland). Values presented were above
the background fluorescence from the empty strain. For measure-
ment of ß-galactosidase activity, pqsA::pqsH cells harboring pGX5,
which carries the pqsA-lacZ reporter gene [51], were diluted to
OD600 nm=0.05; and OD600 nm and ß-galactosidase activity
(expressed as Miller Units) were measured at the indicated optical
densities. Assays were performed in triplicate. All of the experiments
were repeated at least three times.
Construction of pqsB::C
The mutant was constructed as described by Lesic et al [52]
such that most of the pqsB and pqsC genes were replaced with a
Kanamycin resistance marker. The deletion was made from nt
151 in pqsB to nt 456 in pqsC (within the coding regions), leaving
150 bp of the 59 end of the pqsB coding region and 149 bp of the
39 end of the pqsC coding region. The mutants were selected on LB
plates containing Kanamycin (200 mg/ml).
Table 1. List of clones bearing lasR, mexT, and fleQ mutations.
Number of
clones
Nucleotide
position in lasR
Sequence
change
Amino acid
change
1 T452 D Frameshift
2 C192G C–G Stop
1 C174G C–G Ala-Gly
2*(2) T215 D Frameshift
1 C692T C–T Ala-Val
1 C471G C–G Stop
4 G661T G–T Val-Leu
1 T235C T–C Cys-Arg
2*(2) 55–59 D Frameshift
11*(2) $(1) 257–320 D D62
2 67–573 D D168
17 Full gene D Dfull
Mutations in the mexT and fleQ intergenic regions are indicated by * and $,
respectively. The number in parentheses shows the number of clones bearing
the respective mutation.
doi:10.1371/journal.ppat.1002192.t001
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Visualization of 2-AA Affected Cells
PA14 cells harboring the plasmid pAC37, which contained the
pqsA-GFP(ASV) reporter fusion, were grown to mid-logarithmic
phase in the presence of various concentrations of 2-AA. The
cells were washed in phosphate buffered saline (PBS) and their
membranes were stained with FM-64 (Invitrogen) according to
the manufacturer’s instructions. Five-microliter aliquots of
bacterial cells were spotted onto slides and covered with Poly-
L-lysine coated coverslips (Sigma Aldrich, US). The bacteria were
visualized using an Eclipse E800 (Nikon) microscope with FM-64-
stained membranes visualized as red and pqsA-GFP visualized as
green. The pictures were processed using Spot V4.0.9 (Diagnostic
Instruments) software.
Plasmid Construction
To constitutively express pqsABCD, a genomic fragment
containing pqsABCD was amplified by PCR using pqsABamHI 59
CATGGATCCAACGTTCTGTCATGTCCACG39 and PqsDP
st1 59CGACTGCAGTCAACATGGCCGGTTCAC39 primers
from an H44 cosmid [53] as template. The BamH1 and Pst1
digested PCR product was ligated to a pDN18 vector digested
with BamH1 and Pst1. The construct was introduced into E. coli
Top10 (Invitrogen) cells and P. aeruginosa mvfR mutant cells by
electroporation.
To construct pqsA-sucB reporter fusion, the pqsA promoter was
amplified using the primers 59GACTAGTCGAGCAAGGG-
TTGTAACGGTTTTTG39 and 59GAAGATCTGACAGAAC-
GTTCCCTCTTCAGCGA39 and the PA14 chromosome was
used as template. The sacB gene was amplified using the primer
pairs 59GAAGATCTATGAACATCAAAAAGTTTGCA39 and
59AAACTGCAGGTTGATAAGAAATAAAAGAAAATGCC39
from pKOBEG-sacB plasmid [54]. PqsA promoter (PpqsA) was
then digested with SpeI/BglII and the fragment containing sacB
was digested with BglII/PstI. The two fragments were ligated to
the CTX (TetR) plasmid digested with SpeI/BglII. The ligated
vector was eletroporated into E. coli SM10 lambda pir and used to
integrate the CTX-PpqsA-sacB to PA14 chromosome. Rif and
TetR plates were used to select for the PA14 CTX-PpqsA-sacB
clones and the presence of CTX-PpqsA-sacB in the PA14
chromosome was further confirmed by PCR.
Pyocyanin Quantification
Overnight PA14 cultures were diluted to OD600 nm = 0.05 in
5 ml LB or LB +200 mg/ml 2-AA. The bacteria were grown in
triplicate at OD 3.0. Pyocyanin was extracted with chloroform
from 5 ml cell culture supernatant and then extracted with an
equal volume of HCl (0.2 N); optical density was measured at
OD520 nm. The amount of pyocyanin was quantified by
multiplying the OD520 nm value by 17.072 to obtain values in
mg/ml [55].
Pyoverdine Quantification
PA14 bacterial cells (200 ml) were grown in 96-well plates in D-
TSB medium with a range of 2-AA concentrations. The plates
were incubated and pyoverdine production and growth were
measured every 30 min by a Tecan F200 automated plate reader
(Infinite F200, Tecan Group Ltd, Ma¨nnedorf, Switzerland).
Pyoverdine levels were measured using excitation at 400 nm and
emission at 460 nm. The values were normalized to cell growth
(OD600 nm). Pyoverdine concentrations were calculated using a
calibration curve of fluorescence for a range of pyoverdine
concentrations (Sigma Aldrich, USA).
Mortality Studies
Fly mortality. Fly maintenance and the infection assays were
performed as described previously [29]. For the survival assays,
50–60 flies were infected with a bacterial suspension of
56107 cells/ml (grown in LB to OD600 nm= 3.0) in the presence
(1.6 ng of 2-AA /fly) and absence of 2AA. The bacteria were
mixed with 2-AA immediately before injection, and the flies were
incubated at 21uC following infection. Fly mortality was assessed
over time as described previously [29]. The experiment was
performed twice with qualitatively similar results between the
replicates. Bacterial inoculations were accomplished via pricking
the middle dorsolateral thorax of the fly with a needle previously
dipped into the bacterial suspension. The number of inoculated
cells was ,100 (2 nl) on average per fly. Statistical significance of
survival kinetics was assessed by the Kaplan Meier method.
Mouse mortality. A thermal injury mouse model [32] was
used, as described previously [11], to assess bacterial pathogenicity
in 6-week-old CD1 mice (Charles River, Boston, MA, USA). The
animal protocol was approved by the Massachusetts General
Hospital Institutional Animal Care and Use Committee. Following
administration of anesthesia, a full-thickness thermal burn injury
involving 5–8% of the total body surface area was produced on the
dermis of the shaved mouse abdomen, and an inoculum of
2.56105 PA14 cells in 100 ml of saline or 2-AA solution (67 mg of
2-AA in 100 ml saline/mouse, mixture prepared immediately
before injection) was injected intradermaly into the burn eschar.
Mortality was recorded for 1 week. CFU counts were performed
for 5–6 mice per group. Local muscle biopsies underneath the
eschar, and from adjacent muscle on either side of the burn eschar,
20 h post-burn and infection were collected and homogenized in
1 ml of 16PBS. The samples were diluted and plated on LB-agar
plates containing rifampicin (50 mg/L). The systemic spread of
the bacteria was assessed by counting the CFUs in the blood at
20 h post-burn and infection.
Fly Feeding Infection and Bacterial Persistence
Fly feeding on a P. aeruginosa-containing solution was performed
as described previously [28]. Briefly, 5–7-day-old female Oregon-
R flies (N= 26 per group) were fed for 1 d with a mixture of
0.05 ml of LB bacterial culture at OD600 nm= 1.8, 1 ml of 20%
sucrose, and 4 ml of water. Thus, the feeding mix contained a final
concentration of 1% LB, ,36107 bacteria/ml, and 4% sucrose. A
sterile cotton ball was placed at the bottom of each fly vial and was
impregnated with 5 ml of the feeding mix. The flies in each
treatment group were sub-divided into three fly vials (13 flies per
vial), sealed with a clean cotton ball, and incubated at 25uC. A day
later, the flies were transferred to 50 ml plastic screw-cap tubes (10
flies per tube). The tubes were perforated with a heated 0.9-mm
needle to enable aeration, while the caps were perforated with a
heated 1.2-mm needle and covered with a 2.3 cm Whatman disc
(Fisher scientific, USA). A 0.2-ml volume of 4% sucrose solution
was dropped onto the Whatman disc and covered with parafilm to
provide food for the flies with minimal contamination. New fly
tubes were prepared daily and the flies were incubated at 25uC.
CFU counts per fly were measured at the indicated time points by
dipping 6–9 flies per time point in 95% ethanol for 3 s and letting
them dry out on paper tissues (Kimwipes). Then each fly was
ground up using a 1.5-ml tube pestle in 0.1 ml of LB, and 1:10
dilutions were plated on LB plates. Statistical analysis of the CFU
data was performed using the Student’s t-test.
Assessment of Mutations
PA14 and mutS mutant were grown overnight in LB. The
saturated culture was diluted 1:10 in triplicate in 4% sucrose with
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varying concentrations of 2-AA, or without 2-AA. The diluted
cultures were incubated statically at 25uC for 10 d. The cells were
then diluted and plated to allow the numbers of total colonies to be
counted the following day. After 2 d of plating, the lasR cells were
identified by their excessive pyocyanin production. The percent-
age of lasR mutants in each sample was calculated and statistical
significance was determined by Student’s t-test, assuming equal
variance. The lasR mutant colonies were further confirmed by
sequencing of the complete lasR gene. In addition, the complete
sequences of mexA, mexE, mexS, mexT, mexZ, wspF, fleQ, exsA, accC,
vfR, popD, mutS, nfxB, rpoN, rhlR, pqsA, pqsb, pqsE, pqsH, and mvfR
were also determined in these lasR mutant colonies.
Supporting Information
Figure S1 Production Kinetics of 2-AA in Burkholderia
thailandensis. Production kinetics of 2-AA at different stages of
growth. Growth is shown as OD 600 nm. The error bars represent
the standard deviation from 3 replicates.
(EPS)
Figure S2 Levels of 2-AA in various isogenic mutants of
PA14. 2-AA levels were quantified by LC/MS and presented as
relative to WT (PA14) levels at OD 4.0.
(EPS)
Figure S3 DHQ does not affect the expression of the
pqsA promoter, neither 2-AA nor DHQ inhibit bacterial
growth. (A) Expression of pqsA-GFP(ASV) in the presence of
increasing concentrations of DHQ measured as GFP fluorescence
and expressed as relative fluorescence over time. (B and C).
Growth curve of PA14 cells carrying the pqsA-GFP(ASV). Growth
is represented as the OD 600 nm with increasing concentration of
DHQ (B) and 2-AA (C) respectively. The values presented are
average from 6 replicates.
(EPS)
Figure S4 Growth Kinetics of PA14 and pqsB::C mutant
carrying pqsA-SacB reporter. Growth (OD 600 nm) was
recorded in the presence or absence of sucrose (10%) and/or with
exogenously added various concentrations of 2-AA. The pqsA
promoter of pqsA-SacB in the pqsBC mutant was induced by
exogenous addition of 10 mg/ml HHQ where indicated. The
vertical line represents the growth at 20 hours post inoculation.
(EPS)
Figure S5 2-AA inhibits the HAQ analogs in B. thailan-
densi. Production kinetics of HMHQ (A) and HMHNQ (B) in B.
thailandensis supernatants at different growth stages, minus and plus
2-AA. LC/MS data are averaged for triplicate samples.
(EPS)
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